(Q40758036)

23 September 2017

title

Treatment of Kawasaki syndrome: a comparison of two dosage regimens of intravenously administered immune globulin (English)

1 reference

23 September 2017

Barron KS

1

1 reference

23 September 2017

Murphy DJ Jr

2

1 reference

23 September 2017

Silverman ED

3

1 reference

23 September 2017

Ruttenberg HD

4

1 reference

23 September 2017

Wright GB

5

1 reference

23 September 2017

Franklin W

6

1 reference

23 September 2017

Goldberg SJ

7

1 reference

23 September 2017

Higashino SM

8

1 reference

23 September 2017

Cox DG

9

1 reference

23 September 2017

Lee M

10

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 October 1990

1 reference

The Journal of Pediatrics

23 September 2017

published in

1 reference

23 September 2017

volume

117

1 reference

23 September 2017

issue

4

1 reference

23 September 2017

page(s)

638-644

1 reference

High-dose intravenous gammaglobulin for Kawasaki disease

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980707-3

High-dose intravenous gammaglobulin for Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980707-3

High-dose gammaglobulin therapy for Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980707-3

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980707-3

Treatment of Kawasaki syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980707-3

Rickettsia-like bodies and splenitis in Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980707-3

Does Kawasaki disease have a retroviral aetiology?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980707-3

Absence of significant RNA-dependent DNA polymerase activity in lymphocytes from patients with Kawasaki syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980707-3

Characterization of the Polymerase Activity Associated with Cultured Peripheral Blood Mononuclear Cells from Patients with Kawasaki Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980707-3

Scoring method for identifying patients with Kawasaki disease at high risk of coronary artery aneurysms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980707-3

10.1016/S0022-3476(05)80707-3

7 January 2021

Identifiers

DOI

1 reference

23 September 2017

1 reference